These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15808118

  • 21. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 22. Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.
    Leigh R, Vethanayagam D, Yoshida M, Watson RM, Rerecich T, Inman MD, O'Byrne PM.
    Am J Respir Crit Care Med; 2002 Nov 01; 166(9):1212-7. PubMed ID: 12403690
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
    O'Sullivan S, Akveld M, Burke CM, Poulter LW.
    Am J Respir Crit Care Med; 2003 Mar 01; 167(5):745-50. PubMed ID: 12480610
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I, Jerzynska J, Kuna P.
    J Allergy Clin Immunol; 2002 Feb 01; 109(2):257-63. PubMed ID: 11842294
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide.
    Gong H, Linn WS, Terrell SL, Anderson KR, Clark KW.
    Chest; 2001 Feb 01; 119(2):402-8. PubMed ID: 11171715
    [Abstract] [Full Text] [Related]

  • 31. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE, Illamperuma C, Gauvreau GM, Watson RM, O'Byrne PM, Deschesnes F, Boulet LP, Cockcroft DW.
    Eur Respir J; 2009 Jun 01; 33(6):1302-8. PubMed ID: 19164343
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
    Ohbayashi H, Adachi M.
    Allergol Int; 2008 Sep 01; 57(3):231-9. PubMed ID: 18493166
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E, Moske O, Thoma S, Storm Van's Gravesande K, Ihorst G, Brandis M, Kuehr J.
    Pediatr Res; 2003 Aug 01; 54(2):198-203. PubMed ID: 12736396
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB.
    Arch Intern Med; 1998 Jun 08; 158(11):1213-20. PubMed ID: 9625400
    [Abstract] [Full Text] [Related]

  • 39. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.
    N Engl J Med; 1998 Jul 16; 339(3):147-52. PubMed ID: 9664090
    [Abstract] [Full Text] [Related]

  • 40. Montelukast: more than a cysteinyl leukotriene receptor antagonist?
    Tintinger GR, Feldman C, Theron AJ, Anderson R.
    ScientificWorldJournal; 2010 Dec 14; 10():2403-13. PubMed ID: 21170491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.